Pfizer Post-Mortem – Another One Bites the Dust
True to my dividend investing code, I have sold Pfizer after their recently announced 50% dividend cut to offset the purchase of Wyeth. Pfizer has been a stock that I have held for a long time, and held great faith in the company as a strong dividend growth company. However this changed quickly and the [...]
Sold Some Dividend Cut Stocks
In a recent post, I wrote about how I had altered my investing code to reflect that I would now be selling dividend stocks soon after a dividend cut. This is quite a departure for me as I traditionally had not sold stocks very often. However, given my primary objective to generate a reliable and [...]
BCE – A Sell Gone Way Bad
If you have been following my blog for some time now, you will know that I do not sell stocks very often. The stocks I tend to buy, the real blue chip, dividend increasing type of companies never give me much reason to sell. This has worked in my favor more often than not. However, [...]
